A 2024 American Journal of Surgery systematic review places cosmetic surgery regret at roughly 5—33% depending on procedure type: breast augmentation sits at the low end (5—9%), body contouring at the high end (11—33%). That review does not compute a single cross-procedure average, so no single overall rate is shown for elective cosmetic procedures. A companion 2023 PMC narrative summary of the decision-regret literature does not add its own numeric range but corroborates which factors drive regret (see below); the AJS review itself reports rates only. On the inaction side, no large-sample survey directly measures regret about not having cosmetic surgery. The 7% inaction figure is a ceiling proxy — the Ipsos-reported share who say they would be willing to undergo cosmetic surgery to achieve their ideal body — not a measured regret rate or a survey finding about regret.
The 2023 PMC review of the decision-regret literature (not the 2024 AJS review, which reports rates only) identifies inadequate preoperative education, limited use of decisional tools, and postoperative complications as the strongest predictors of regret.
The main caveat is the asymmetry of evidence. The action side has genuine peer-reviewed systematic reviews with procedure-specific breakdowns. The inaction side has essentially nothing: body dissatisfaction surveys measure a different construct, and ASDS consideration rates conflate casual curiosity with genuine surgical intent. The 7% inaction figure used here is a ceiling proxy — willingness to undergo cosmetic surgery, not a measured regret rate. If a rigorous survey ever asks a representative sample of non-patients “Do you regret not having cosmetic surgery?”, the true figure could be higher or lower. Until then, no comparison between the two sides should be read as a precise quantitative claim.







